Products Categories
    Product Certification&
    Enterprise Certification

  • Ms.Jessica
    Tel: +86-18591943808

  • Ms.Alisa
    sales
    Tel: +086 15594841756

  • Mobile:+8618591943808
  • Tel:+86-18591943808
  • Fax:+86--29-86333380
  • URL:http://www.xazbbio.cn
  • Province/state:Shaanxi
  • City:Xi'an
  • Street:Bldg. 3, East Of South Tangyan Road, High-Tech Zone, Xi'an, Shaanxi, China (Mainland)
  • MaxCard:
Home > Products >  99% Fluralaner Powder

99% Fluralaner Powder CAS NO.864731-61-3

  • Min.Order: 1 Gram
  • Payment Terms: T/T,MoneyGram,Other
  • Product Details

Keywords

  • Fluralaner 99%
  • Fluralaner
  • 864731-61-3

Quick Details

  • ProName: 99% Fluralaner Powder
  • CasNo: 864731-61-3
  • Molecular Formula: C22H17Cl2F6N3O3
  • Appearance: White Powder
  • Application: pharmaceuticals
  • DeliveryTime: 3days after we receive the payment
  • PackAge: 1> 25kg: Packed with paper drum with d...
  • Port: Shanghai, Tianjin or other China main ...
  • ProductionCapacity: 1000 Kilogram/Month
  • Purity: 99.5%
  • Storage: Cool and dry place
  • Transportation: Air/Sea/Express
  • LimitNum: 1 Gram
  • Related Substances: 99.5%
  • Residue on Ignition: <1ppm
  • Heavy Metal: <1ppm
  • Valid Period: 24 months
  • pH: 6.0-7.5
  • Loss on drying: <5%
  • Heavy metal(Pb): <10ppm
  • Mold and Yeast: <10cfu/g
  • Relevant impurity: ≤0.5%
  • Ash: ≤10%
  • Iron: ≤50ppm
  • Sulfate: ≤50ppm
  • Arsenic: ≤2ppm
  • Lead: ≤3ppm
  • Mercury: ≤0.1ppm

Superiority

Our Company

Xi'an ZB Biotech Co., Ltd is specialized in researching, producing and selling herbal extract and API powder, which are mainly used in nutraceutical, cosmetic, beverage and food additives etc.
Owing plant base, extracting and purifying in GMP workshop, concentrating on the quality and cost each link. That XAZB Biotech is aiming of benefiting the world with lowest price but best products.


We are keeping overcritical on the quality and persisting in the profession all the time. XAZB owns two standardized production workshops, advanced multifunction extractors and juice concentrate equipment, covering 12,000m2. annual dried material processed 950MT, monthly production ability 60MT. 32 scientists are in R&D team. We have strict QC standards and perfect quality guarantee system, GMP certified, also FDA, ISO9001 and Halal certified. 

We also build an integrative marketing center in Xi'an city, China, involving in research, test, sale and service. With full qualification and exporting experience, our products are widely sold to more than 40 countries from Europe, America, Southeast Asia, Oceania and so on


1. High quality with competitive price:
We are manufacturer and we have 2 factories in China,we can provide excellent quality products with factory price.


2. Fast and safe delivery:
1) Parcels can be sent out within 3 days after payment. Tracking number is available.
2) Secure and discreet shipment. You have various choices of transportation methods.

3. We have clients throughout the world:
1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet your desire.
2) Market feedback and goods feedback are appreciated, meeting customers's requirement is our  responsibility.
3) High quality, competitive price, fast delivery, first-class service gain the trust and praise from the customers.

4. Exported areas: Europe , southeast Asia , the Middle East , Africa , South America and some other countries and areas.
 
5
We manufacture Herbal Extract and Active Pharmaceutical Ingredients products.

Business scope: Organic & Inorganic Chemicals , Pigments & Dye stuffs , Water treatment chemicals, Intermediates, Food & FEED additives and other.

Details

Product Name: Fluralaner
Synonyms: Fluralaner;4-(5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-2-methyl-N-(2-oxo-2-(2,2,2-trifluoroethylamino)ethyl)benzamide;4-[(5R)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide;A1443; AH252723;AH252723;Benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-;Fluralaner fandachem
CAS: 864731-61-3
MF: C22H17Cl2F6N3O3
MW: 556.29
EINECS: 689-035-6
Product Categories: 1
Mol File: 864731-61-3.mol
Fluralaner Structure
 
Fluralaner Chemical Properties
density  1.51±0.1 g/cm3(Predicted)
pka 12.50±0.46(Predicted)

Description Fluralaner (INN) is a systemic insecticide and acaricide that is administered orally. The U.S. Food and Drug Administration (FDA) approved it under the trade name Bravecto for flea treatment in dogs in May 2014. The EU approved the drug in February 2014. Australia approved it for the treatment and prevention of ticks and fleas on dogs in January 2015.
Uses Fluralaner is an insecticide and acaricide used to treat Sarcoptes scabiei var. canis infestation in dogs. Flea treatment. A possible anti-malarial found to kill disease-spreading mosquitoes when they bite treated people.
Mode of action Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABAA receptors) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a related GABA-antagonist insecticide and acaricide).

Pharmacodynamic properties Fluralaner is an acaricide and insecticide. It is efficacious against ticks (Ixodes spp., Dermacentor spp. and Rhipicephalus sanguineus) and fleas (Ctenocephalides spp.) on the dog.
Fluralaner has a high potency against ticks and fleas by exposure via feeding, i.e. it is systemically active on target parasites.
Fluralaner is a potent inhibitor of parts of the arthropod nervous system by acting antagonistically on ligand-gated chloride channels (GABA-receptor and glutamate-receptor).
In molecular on-target studies on insect GABA receptors of flea and fly, fluralaner is not affected by dieldrin resistance. In in vitro bio-assays, fluralaner is not affected by proven field resistances against amidines (tick), organophosphates (tick, mite), cyclodienes (tick, flea, fly), macrocyclic lactones (sea lice), phenylpyrazoles (tick, flea), benzophenyl ureas (tick), pyrethroids (tick, mite) and carbamates (mite).
The product contributes towards the control of the environmental flea populations in areas to which treated dogs have access.
Newly emerged fleas on a dog are killed before viable eggs are produced. An in vitro study also demonstrated that very low concentrations of fluralaner stop the production of viable eggs by fleas. The flea life cycle is broken due to the rapid onset of action and long lasting efficacy against adult fleas on the animal and the absence of viable egg production.
Pharmacokinetics Following oral administration, fluralaner is readily absorbed reaching maximum plasma concentrations within 1 day. Food enhances the absorption. Fluralaner is systemically distributed and reaches the highest concentrations in fat, followed by liver, kidney and muscle. The prolonged persistence and slow elimination from plasma (t1/2 = 12 days) and the lack of extensive metabolism provide effective concentrations of fluralaner for the duration of the inter-dosing interval. Individual variation in Cmax and t1/2 was observed. The major route of elimination is the excretion of unchanged fluralaner in faeces (~90% of the dose). Renal clearance is the minor route of elimination.
Drug interactions Fluralaner is highly bound to plasma proteins and might compete with other highly bound drugs such as non-steroidal anti-inflammatory drugs (NSAIDs) and the cumarin derivative warfarin. Incubation of fluralaner in the presence of carprofen or warfarin in dog plasma at maximum expected plasma concentrations did not reduce the protein binding of fluralaner, carprofen or warfarin.
During clinical field testing, no interactions between Bravecto chewable tablets for dogs and routinely used veterinary medicinal products were observed.
Overdosage No adverse reactions were observed following oral administration to puppies aged 8–9 weeks and weighing 2.0–3.6 kg treated with overdoses of up to 5 times the maximum recommended dose (56 mg, 168 mg and 280 mg fluralaner/kg bodyweight) on three occasions at shorter intervals than recommended (8-week intervals).
There were no findings on reproductive performance and no findings of concern on offspring viability when fluralaner was administered orally to Beagle dogs at overdoses of up to 3 times the maximum recommended dose (up to 168 mg/kg bodyweight of fluralaner).
The veterinary medicinal product was well tolerated in Collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose (168 mg/kg bodyweight). No treatment-related clinical signs were observed.

Our Services

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog